NASDAQ:DARE - Dare Bioscience Stock Price, Forecast & News

Dare Bioscience trades on the NASDAQ under the ticker symbol "DARE."

Dare Bioscience Inc (NASDAQ:DARE) issued its quarterly earnings results on Thursday, November, 14th. The biotechnology company reported ($0.20) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.21) by $0.01. View Dare Bioscience's Earnings History.

Dare Bioscience is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Dare Bioscience.

2 brokers have issued twelve-month target prices for Dare Bioscience's shares. Their forecasts range from $3.00 to $3.00. On average, they anticipate Dare Bioscience's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 119.0% from the stock's current price. View Analyst Price Targets for Dare Bioscience.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dare Bioscience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dare Bioscience.

Media headlines about DARE stock have trended very negative on Monday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Dare Bioscience earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Dare Bioscience.

Dare Bioscience saw a increase in short interest during the month of January. As of January 15th, there was short interest totalling 649,000 shares, an increase of 5.8% from the December 31st total of 613,500 shares. Based on an average daily volume of 1,260,000 shares, the short-interest ratio is presently 0.5 days. Approximately 3.9% of the company's shares are short sold. View Dare Bioscience's Current Options Chain.

Some companies that are related to Dare Bioscience include Elite Pharmaceuticals (ELTP), Stealth BioTherapeutics (MITO), Onconova Therapeutics (ONTX), Eyenovia (EYEN), Trevena (TRVN), Chembio Diagnostics (CEMI), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), CTI BioPharma (CTIC), DiaMedica Therapeutics (DMAC), Aridis Pharmaceuticals (ARDS), Catabasis Pharmaceuticals (CATB), Soligenix (SNGX), Q BioMed (QBIO) and SCYNEXIS (SCYX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Dare Bioscience investors own include FuelCell Energy (FCEL), Protalix Biotherapeutics (PLX), AVEO Pharmaceuticals (AVEO), Catalyst Pharmaceuticals (CPRX), Novavax (NVAX), Tonix Pharmaceuticals (TNXP), BIOLINERX LTD/S (BLRX), Inovio Pharmaceuticals (INO), Synergy Pharmaceuticals (SGYP) and AEterna Zentaris (AEZS).

Dare Bioscience's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Interwest Venture Management Co. (0.30%) and Virtu Financial LLC (0.30%). View Institutional Ownership Trends for Dare Bioscience.

DARE stock was bought by a variety of institutional investors in the last quarter, including Interwest Venture Management Co. and Virtu Financial LLC. View Insider Buying and Selling for Dare Bioscience.

Shares of DARE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DARE stock can currently be purchased for approximately $1.37.

Dare Bioscience has a market capitalization of $22.86 million. The biotechnology company earns $-16,740,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Dare Bioscience employs 5 workers across the globe.View Additional Information About Dare Bioscience.

The official website for Dare Bioscience is http://www.darebioscience.com/.

Dare Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at 858-926-7655 or via email at [email protected]